Toxoplasmosis, caused by the protozoan Toxoplasma gondii, remains a significant global health challenge, particularly for immunocompromised individuals. Current therapies, based on pyrimethamine and sulfadiazine, are limited by toxicity, suboptimal efficacy, and the emergence of resistant parasite strains, highlighting...
Ingrid de Oliveira Dias, Gabriel Cândido Moura, Lucas Manoel da Silva Sousa et al.· ACS Omega· 0 citations
Findings identify a novel chemical scaffold with promising antitrypanosomatid potential that warrants further optimization to improve in vivo performance of chagas disease and leishmaniasis.
Anderson José Firmino Santos da Silva, Daiane Santiago da Cruz Olimpio, Lucas Manoel da Silva Sousa et al.· ChemMedChem· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.